Computational Prediction of Blood-Brain Barrier Permeability Using Decision Tree Induction

by Jörg Huwyler, Felix Hammann, Claudia Suenderhauf
Published 2012-08-01

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety

by Carlos Chaccour, Felix Hammann, N. Regina Rabinovich
Published 2017-04-01

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects

by Patrick C. Dolder, Petra Strajhar, Patrick Vizeli, Felix Hammann, Alex Odermatt, Matthias E. Liechti
Published 2017-09-01

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing

by Charlotte Kern, Charlotte Kern, Verena Schöning, Carlos Chaccour, Carlos Chaccour, Carlos Chaccour, Felix Hammann
Published 2021-03-01

The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes.

by Urs Duthaler, Michael Weber, Lorenz Hofer, Carlos Chaccour, Marta Maia, Pie Müller, Stephan Krähenbühl, Felix Hammann
Published 2021-03-01

Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital

by Verena Schöning, Evangelia Liakoni, Christine Baumgartner, Aristomenis K. Exadaktylos, Wolf E. Hautz, Andrew Atkinson, Felix Hammann
Published 2021-02-01

Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

by Patricia Nicolas, Caroline Kiuru, Martin G. Wagah, Martha Muturi, Urs Duthaler, Felix Hammann, Marta Maia, Carlos Chaccour
Published 2021-03-01

Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae

by Carlos J. Chaccour, Felix Hammann, Marta Alustiza, Sandra Castejon, Brian B. Tarimo, Gloria Abizanda, Ángel Irigoyen Barrio, Helena Martí Soler, Rafael Moncada, José Ignacio Bilbao, Azucena Aldaz, Marta Maia, José Luis Del Pozo
Published 2017-08-01

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the fi...

by Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, Gemma Moncunill, Aina Casellas, Francisco Carmona-Torre, Miriam Giráldez, Juana Schwartz Mota, José Ramón Yuste, José Ramón Azanza, Miriam Fernández, Gabriel Reina, Carlota Dobaño, Joe Brew, Belen Sadaba, Felix Hammann, Regina Rabinovich
Published 2020-06-01

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomiz...

by Carlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz-Castillo, Mary-Ann Richardson, Mariano Rodríguez-Mateos, Carlota Jordán-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giráldez, Ester Laso, Juan C. Gabaldón-Figueira, Carlota Dobaño, Gemma Moncunill, José R. Yuste, Jose L. Del Pozo, N.Regina Rabinovich, Verena Schöning, Felix Hammann, Gabriel Reina, Belen Sadaba, Mirian Fernández-Alonso
Published 2021-02-01